There is currently no FDA-approved treatment or drug for ME/CFS. As neither a cause nor cure for ME/CFS has been identified, treatment is directed at relieving
We're attacking CF from every angle. View the current status of CF drugs in development or already in use by patients below.
This can be further compounded by CF comorbidities such as gastro-oesophageal reflux, constipation, CF related liver disease and CF related
Tramadol, CF=0.1; Oxycodone, CF=1; Methadone, CF= 1.5, Oxymorphone, CF=2; Hydromorphone, CF=4; Morphine, CF=0.5; Codeine, CF=0.15. These CFs cannot be used to convert from hydrocodone extended-release to the selected oral opioid as doing so will result in overestimation of the oral opioid dose and may result in fatal respiratory depression.
Conversion Factors: Hydromorphone, CF=1; Codeine, CF=0.06; Hydrocodone, CF=0.4; Oxycodone, CF=0.4; Methadone, CF=0.6; Morphine, CF=0.2, Oxymorphone, CF=0.6 NOTE: Product of dose and CF does not represent an equianalgesic dose and therefore should not be used to convert hydromorphone extended-release tablets to another opioid
In FMS/CFS patients with an autoimmune prbblem, Mease has noticed that Plaquenil can sometimes help the FMS/CFS symptoms. This drug can cause toxicities in the
For prior opioid use of MORPHINE: Oral CF is 0.5; Parenteral CF is 3 For prior opioid use of TRAMADOL: Oral CF is 0.17; Parenteral CF is 0.2 For patients receiving high-dose parenteral opioids, a more conservative CF is warranted (e.g, for high-dose parenteral morphine, use a CF of 1.5 instead of a CF of 3)
Conversion Factors: Hydromorphone, CF=1; Codeine, CF=0.06; Hydrocodone, CF=0.4; Oxycodone, CF=0.4; Methadone, CF=0.6; Morphine, CF=0.2, Oxymorphone, CF=0.6; NOTE: Product of dose and CF does not represent an equianalgesic dose and therefore should not be used to convert hydromorphone extended-release tablets to another opioid
by DD Garcia-de la Cruz 2024Cases with cf-mtDNA compared to cases without cf-mtDNA. All tests drugs cause a decrease in cf-mtDNA levels. Finally, we did not
Comments
Full marks!